Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.35 |
| ▸ | TRPM8 | Q7Z2W7 | 5/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3671630 | 1.00 | TSHR (0.40) | TSHRTHRBDNM1TRPM8OPRM1 | |
| SCHEMBL180874 | 1.00 | TSHR (0.40) | TSHRTHRBDNM1TRPM8OPRM1 | |
| SCHEMBL3673386 | 0.95 | TSHR (0.40) | TSHRTHRBDNM1TRPM8OPRM1 | |
| SCHEMBL80551 | 0.95 | TSHR (0.40) | TSHRTHRBDNM1TRPM8OPRM1 | |
| SCHEMBL27507309 | 0.93 | TSHR (0.38) | TSHRTHRBDNM1TRPM8OPRM1 | |
| SCHEMBL11664749 | 0.93 | TSHR (0.38) | TSHRTHRBDNM1TRPM8OPRM1 | |
| SCHEMBL818787 | 0.93 | TSHR (0.38) | TSHRTHRBDNM1TRPM8OPRM1 | |
| SCHEMBL7932503 | 0.92 | TSHR (0.35) | TSHRTHRBDNM1TRPM8OPRM1 | |
| SCHEMBL9408974 | 0.90 | TSHR (0.33) | TSHRTHRBTRPM8OPRM1LMNA | |
| Dipentylamine SCHEMBL4944601 | 0.88 | TSHR (0.50) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 736 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6184299-B1 | Staged reactor process | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION | 2001-02-06 | — | — | US | claimed |
| EP-1041088-A1 | Staged reactor polymerisation process | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2000-10-04 | — | — | EP | claimed |
| EP-0712871-A1 | Process for the production of homogeneous ethylene propylene rubbers using a vanadium catalyst supported on magnesium chloride | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1996-05-22 | — | — | EP | claimed |
| US-12624136-B2 | Phthalate-free polypropylene homopolymer having high stiffness properties | W.R. GRACE & CO.- CONN (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260103548-A1 | PROCESS FOR PRODUCING POLYPROPYLENE-ETHYLENE RANDOM COPOLYMER RESIN WITH SUSTAINABLE REACTOR OPERABILITY | W. R. GRACE & CO.-CONN. | 2026-04-16 | — | — | US | disclosed |
| US-12528762-B2 | Catalyst composition for polyolefin polymers | W.R. GRACE & CO.-CONN (US) | 2026-01-20 | — | — | US | disclosed |
| US-12503581-B2 | Foamed article with excellent stiffness preservation and superior surface quality | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2025-12-23 | — | — | US | disclosed |
| US-20250382394-A1 | CATALYST SYSTEM FOR POLYMERIZATION OF AN OLEFIN | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2025-12-18 | — | — | US | disclosed |
| US-20250340725-A1 | Polypropylene Copolymer With High Clarity and Toughness | W. R. GRACE & CO.-CONN. | 2025-11-06 | — | — | US | disclosed |
| US-12441875-B2 | Heterophasic propylene copolymer composition with low gloss | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2025-10-14 | — | — | US | disclosed |
| US-20250235842-A1 | GAS-PHASE PROCESS FOR MAKING POLYPROPYLENE RANDOM COPOLYMERS | W.R. GRACE & CO.-CONN (US) | 2025-07-24 | — | — | US | disclosed |
| US-4755495-A | Process for activation of titanium and vanadium catalysts useful in ethylene polymerization | UNION CARBIDE CORPORATION (US) | 1988-07-05 | — | — | US | disclosed |
| CN-87107589-A | ETHYLENE ROLYMERIZATION CATALYST | — | 1988-05-18 | — | — | CN | disclosed |
| WO-1988002377-A1 | ETHYLENE POLYMERIZATION CATALYST | UNION CARBIDE CORPORATION (US) | 1988-04-07 | — | — | WO | disclosed |
| WO-1988002376-A1 | PROCESS FOR THE POLYMERIZATION OF A LIQUID MONOMER | UNION CARBIDE CORPORATION (US) | 1988-04-07 | — | — | WO | disclosed |
| CN-87101861-A | Trimerization process | — | 1987-09-23 | — | — | CN | disclosed |
| EP-0237079-A1 | Process for trimerization | UNION CARBIDE CORPORATION (US) | 1987-09-16 | — | — | EP | disclosed |
| EP-0234574-A1 | Process for activation of titanium and vanadium catalysts useful in ethylene polymerization | UNION CARBIDE CORPORATION (US) | 1987-09-02 | — | — | EP | disclosed |
| US-4670526-A | TREATMENT WITH MAGNESIUM HALIDE AND LEWIS ACID TO FORM COMPLE X | UNION CARBIDE CORPORATION (US) | 1987-06-02 | — | — | US | disclosed |
| US-4668838-A | OLEFIN WITH CHROMIUM, ALUMINUM, LIGAND CATALYSTS | UNION CARBIDE CORPORATION (US) | 1987-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103548-A1 | PROCESS FOR PRODUCING POLYPROPYLENE-ETHYLENE RANDOM COPOLYMER RESIN WITH SUSTAINABLE REACTOR OPERABILITY | CCT4, PTGER1, TCP1 | TSHR 3426/4885THRB 2073/4885DNM1 1621/4885 |
| US-12624136-B2 | Phthalate-free polypropylene homopolymer having high stiffness properties | TPR, SMCHD1, TELO2 | TSHR 1053/4885THRB 1134/4885DNM1 4745/4885 |
| US-12528762-B2 | Catalyst composition for polyolefin polymers | TKT, TCP1, PPT1 | TSHR 2640/4885THRB 2341/4885DNM1 1577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.